Abstract:Ergothioneine (EGT) has attracted great attention due to its extremely potent antioxidant properties, universally acknowledged as 'longevity vitamin'. In order to comprehensive understanding of its pharmacodynamics and pharmacokinetics, the binding mechanism of EGT with human serum albumin (HSA) was clarified by cutting-edged multi-spectroscopic approaches and in silico molecular docking coupled with molecular dynamic simulation. Our fluorescence quenching results revealed that the binding of EGT to HSA was in a static quenching mode validated by the descending Stern–Volmer constant ( K sv ) values (2.82, 2.36, 1.48 × 10 4 L mol −1 ) and biomolecular quenching rate constant ( K q ) values (2.82, 2.36, 1.48 × 10 12 L mol −1 ) at 298 K, 305 K, and 310 K, respectively. van't Hoff criterion revealed the combination of EGT with HSA was a spontaneous exothermic process (Δ G = −24.16 kJ mol −1 ) via hydrogen bonding and van der Waals force interactions (Δ H = −60.25 kJ mol −1 , Δ S = −129.44 J mol −1 K −1 ) at 310 K. The analysis of UV–vis absorption spectrum, synchronous fluorescence spectrum, three-dimensional fluorescence spectrum and circular dichroism indicated the addition of EGT affected the microenvironment of Trp214 and rearranged the structure of HSA. The binding replacement assay interpreted their binding site was near the subdomain IIA of HSA (Sudlow's site I), which was intuitively exhibited by molecular docking. In addition of obvious van der Wall forces, attractive charge and Pi-alkyl interactions, the chiral betaine group (N + (CH 3 + ) 3 ) in the side chain of EGT was inclined to form hydrogen bonds with Lys199, Ser287 and Arg257 in the hydrophobic cavity of albumin. Moreover, the dynamic simulation reinforced the equilibrium and stability of formed docking complex by four indicators (RMSD, RMSF, Rg, SASA) within 100 ns.

Assessment of the binding mechanism of ergothioneine to human serum albumin: Multi-spectroscopy, molecular docking and molecular dynamic simulation

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Studies of Interaction Between Ergosta‐4,6,8(14),22‐tetraen‐3‐one (ergone) and Human Serum Albumin by Molecular Spectroscopy and Modeling

Deciphering the binding mechanisms of eugenol and 2-methylpyrazine with human serum albumin using technical approach

Human Serum Albumin as an Antioxidant in the Oxidation of (−)-Epigallocatechin Gallate: Participation of Reversible Covalent Binding for Interaction and Stabilization

Interaction of (-)-epigallocatechin-3-gallate with human serum albumin: fluorescence, fourier transform infrared, circular dichroism, and docking studies

Combined Molecular Docking and Multi-Spectroscopic Investigation on the Interaction Between Eosin B and Human Serum Albumin

Study of the Binding Mechanism Between Hydroxytyrosol and Bovine Serum Albumin Using Multispectral and Molecular Docking

The effect of Berberine on the secondary structure of human serum albumin

Fluorescence Spectroscopy and Molecular Docking Approach to Probe the Interaction Between Dehydroeburicoic Acid and Human Serum Albumin

Study of the Interaction Between Esculetin and Human Serum Albumin by Multi-Spectroscopic Method and Molecular Modeling

Study on the interaction between vitamin D3 and human serum albumin by a combination of spectroscopy and molecular modeling

Studies On The Fluorescence Enhancement Effect Of Ergosta-4,6,8(14),22-Tetraen-3-One With Serum Albumin And Its Application

Conformation and Aggregation of Human Serum Albumin in the Presence of Green Tea Polyphenol (EGCg) and/or Palmitic Acid

Effect of (–)-epicatechin-3-gallate and (–)-epigallocatechin-3-gallate on the binding of tegafur to human serum albumin as determined by spectroscopy, isothermal titration calorimetry, and molecular docking

Evaluation of non-covalent interactions between serum albumin and green tea catechins by affinity capillary electrophoresis

Molecular Docking and Spectroscopic Methods to Probe the Interaction of Acetylgliotoxin and HSA

Insights into the Binding of 2-Aminobenzothiazole with Human Serum Albumin (HSA): Spectroscopic Investigation and Molecular Modeling Studies.

Characterization of taurine and its derivative binding to HSA using calorimetry and docking

Spectroscopic and in Silico Study of Binding Mechanism of Cynidine-3-o-glucoside with Human Serum Albumin and Glycated Human Serum Albumin.

Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy